IL13 and chronic rhinosinusitis with nasal polyps: In an in vitro study using air liquid interface (ALI) cultures of primary bronchial epithelial cells treated with IL-5, IL-13, and IL-33, from patients with chronic rhinosinusitis with nasal polyps (CRSwNP), only IL-13 promoted RA generation (25).